Tag: Drug approvals

Governors pin hopes on full vaccine approval as cases climb

0
LITTLE ROCK, Ark. — As U.S. regulators weigh giving the final stamp of approval for certain COVID-19 vaccines, governors in states hard hit by...

France allows visitors with Indian-made AstraZeneca vaccine

0
PARIS — France will allow international travelers who have had AstraZeneca’s Indian-manufactured vaccine into the country starting Sunday. ...

New Merck pneumonia vaccine OK’d in US weeks after Pfizer’s

0
U.S. regulators have approved a new pneumonia vaccine from Merck, more than a month after OK'ing an improved version of rival Pfizer’s shot. ...

Medicare evaluating coverage for $56,000 Alzheimer’s drug

0
WASHINGTON — Medicare on Monday launched a formal process to decide whether to cover Aduhelm, the new Alzheimer's drug whose $56,000-a-year price tag and...

FDA head calls for probe into Alzheimer’s drug review

0
WASHINGTON — The acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual contacts between some...

FDA trims use of contentious Alzheimer’s drug amid backlash

0
WASHINGTON — U.S. health regulators on Thursday approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer’s drug. ...

Does new Alzheimer’s drug work? Answers may miss 2030 target

0
WASHINGTON — When a controversial Alzheimer’s drug won U.S. approval, surprise over the decision quickly turned to shock at how long it might take...

Putin reveals he was vaccinated with Russia’s Sputnik V

0
MOSCOW — President Vladimir Putin revealed Wednesday that he had received the domestically developed Sputnik V vaccine earlier this year, stressing the importance of...

Alzheimer’s drug stirs hope for patients, worry for doctors

0
In the weeks since a new Alzheimer's drug was approved, hopeful patients have bombarded Dr. Alireza Atri with calls and emails about a treatment...

Lilly to seek FDA approval for potential Alzheimer’s drug

0
INDIANAPOLIS — Eli Lilly said Thursday that it will submit its potential Alzheimer’s treatment to federal regulators later this year. ...